Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 1 , Pages 44-52 , March 2007

Topical 5-aminolevulinic acid-mediated photodynamic therapy for oral verrucous hyperplasia, oral leukoplakia and oral erythroleukoplakia

  • Hsin-Ming Chen

      Affiliations

    • Department of Dentistry, National Taiwan University Hospital, Taipei 100, Taiwan
    • School of Dentistry, College of Medicine, National Taiwan University, Taipei 100, Taiwan
  • ,
  • Chuan-Hang Yu

      Affiliations

    • Graduate Institute of Clinical Dentistry, National Taiwan University, Taipei 100, Taiwan
  • ,
  • Tsuimin Tsai

      Affiliations

    • Graduate Institute of Biomedical Materials, Taipei Medical University, Taipei 110, Taiwan
  • ,
  • Yih-Chih Hsu

      Affiliations

    • Biomedical Engineering Center, Industrial Technology Research Institute, Hsinchu 310, Taiwan
    • Department of Biomedical Engineering, Chung Yuan Christian University, Chung Li 320, Taiwan
  • ,
  • Ru-Cheng Kuo

      Affiliations

    • Department of Dentistry, National Taiwan University Hospital, Taipei 100, Taiwan
  • ,
  • Chun-Pin Chiang, DDS, DMSc

      Affiliations

    • Department of Dentistry, National Taiwan University Hospital, Taipei 100, Taiwan
    • School of Dentistry, College of Medicine, National Taiwan University, Taipei 100, Taiwan
    • Graduate Institute of Clinical Dentistry, National Taiwan University, Taipei 100, Taiwan
    • Corresponding Author InformationCorresponding author at: Department of Dentistry, National Taiwan University Hospital, No. 1, Chang-Te Street, Taipei 100, Taiwan. Tel.: +886 2 2312 3456x6855; fax: +886 2 2389 3853.

References 

  1. Lingen M, Sturgis EM, Kies MS. Squamous cell carcinoma of the head and neck in non-smokers: clinical and biologic characteristics and implications for management. Curr Opin Oncol. 2001;13:176–182
  2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  3. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30
  4. Taiwan area main causes of death 2004. Department of Health, The Executive Yuan, Taiwan, R.O.C; 2005.
  5. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med. 1995;24:450–453
  6. Kwan HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: a preliminary report. J Formos Med Assoc. 1976;75:497–505
  7. Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol. 1999;35:173–179
  8. Neville BW, Damm DD, Allen CM, Bouquot JE. Epithelial pathology. In:  Neville BW,  Damm DD,  Allen CM,  Bouquot JE editor. Oral and maxillofacial pathology. 2nd ed.. Philadelphia: W.B. Saunders Company; 2002;p. 337–346
  9. Hogewind WF, van der Kwast WA, van der Wall I. Oral leukoplakia, with emphasis on malignant transformation. A follow-up study of 46 patients. J Craniomaxillofac Surg. 1989;17:128–133
  10. Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer. 1984;53:563–568
  11. Shiu MN, Chen THH. Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer. Eur J Cancer Prev. 2004;13:39–45
  12. Karrer S, Szeimies RM, Hohenleutner U, Landthaler M. Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Am J Clin Dermatol. 2001;2:229–237
  13. Kubler A, Haase T, Rheinwald M, Barth T, Muhling J. Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. Int J Oral Maxillofac Surg. 1998;27:466–469
  14. Sieron A, Namyslowski G, Misiolek M, Adamek M, Kawczyk-Krupka A. Photodynamic therapy of premalignant lesions and local recurrence of laryngeal and hypopharyngeal cancers. Eur Arch Oto-Rhino-Laryngol. 2001;258:349–352
  15. Sieron A, Adamek M, Kawczyk-Krupka A, Mazur S, Ilewicz L. Photodynamic therapy (PDT) using topically applied δ-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J Oral Pathol Med. 2003;32:330–336
  16. Tsai JC, Chiang CP, Chen HM, et al. Photodynamic therapy of oral dysplasia with topical 5-aminolevulinic acid and light-emitting diode array. Lasers Surg Med. 2004;34:18–24
  17. Chen HM, Chen CT, Yang H, et al. Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Oral Oncol. 2004;40:630–637
  18. Chen HM, Yu CH, Tu PC, Yeh CY, Tsai T, Chiang CP. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Lasers Surg Med. 2005;37:114–122
  19. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3:380–387
  20. Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J Clin Laser Med Surg. 1996;14:289–304
  21. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogeneous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B: Biol. 1990;6:143–148
  22. Gossner L, Stolte M, Sroka R, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology. 1998;114:448–455
  23. Berger AP, Steiner H, Stenzl A, Akkad T, Bartsch G, Holtl L. Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study. Urology. 2003;61:338–341
  24. Gold MH, Gold man MP. 5-Aminolevulinic acid photodynamic therapy: where we have been and where we are going. Dematol Surg. 2004;30:1077–1083
  25. Gupta AK, Ryder JE. Photodynamic therapy and topical aminolevulinic acid: an overview. Am J Clin Dermatol. 2003;4:699–708
  26. Grant WE, Hopper C, MacRobert AJ, Speight PM, Bown SG. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid. Lancet. 1993;342:147–148
  27. Fan KF, Hopper C, Speight PM, Buonaccorsi G, MacRobert AJ, Bown SG. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer. 1996;78:1374–1383
  28. Chen HM, Chen CT, Yang H, et al. Successful treatment of an extensive verrucous carcinoma with topical 5-aminolevulinic acid-mediated photodynamic therapy. J Oral Pathol Med. 2005;34:253–256
  29. Barr H, Shepherd NA, Dix A, Roberts DJ, Tan WC, Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet. 1996;348:584–585
  30. Ackroyd R, Brown NJ, Davis MF, et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomized, placebo controlled trial. Gut. 2000;47:612–617
  31. Bodner K, Bodner-Adler B, Wierrani F, et al. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results. Anticancer Res. 2003;23:1785–1788
  32. Waidelich R, Stepp H, Baumgartner R, Weninger E, Hofstetter A, Kriegmair M. Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer. J Urol. 2001;165:1904–1907
  33. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy. Cancer. 1997;79:2282–2308
  34. Leunig A, Rick K, Stepp H, et al. Fluorescence imaging and spectroscopy of 5-aminolevulinic acid induced protoporphyrin IX for the detection of neoplastic lesions in the oral cavity. Am J Surg. 1996;172:674–677
  35. Leunig A, Betz CS, Mehlmann M, et al. Detection of squamous cell carcinoma of the oral cavity by imaging 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Laryngoscope. 2000;110:78–83
  36. Leunig A, Mehlmann M, Betz C, et al. Fluorescence staining of oral cancer using a topical application of 5-aminolevulininc acid: fluorescence microscopic studies. J Photochem Photobiol B: Biol. 2001;60:44–49
  37. Kingsbury JS, Cecere W, Mang TS, Liebow C. Photodynamic therapy for premalignant lesions in DMBA-treated hamsters: a preliminary study. J Oral Maxillofac Surg. 1997;55:376–381
  38. Grant WE, Hopper C, Speight PM, Macrobert AJ, Bown SG. Photodynamic therapy of malignant and premalignant lesions in patients with “field cancerization” of the oral cavity. J Laryngol Otol. 1993;107:1140–1145
  39. Campbell SM, Dould DJ, Salter L, Clifford T, Curnow A. Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia. Br J Dermatol. 2004;151:1076–1080

PII: S1572-1000(06)00151-7

doi: 10.1016/j.pdpdt.2006.11.003

Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 1 , Pages 44-52 , March 2007